Compugen Announces Presentations at Three Upcoming Cancer Immunotherapy Conferences – PR Newswire (press release)
|
Compugen Announces Presentations at Three Upcoming Cancer Immunotherapy Conferences
PR Newswire (press release) Compugen Ltd. (NASDAQ: CGEN), a leader in predictive discovery and development of first-in-class therapeutics for cancer immunotherapy, today announced upcoming poster and oral presentations on COM701, a first-in-class therapeutic antibody candidate … |
